MaxCyte, Inc. (LON:MXCT – Get Free Report)’s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 322.33 ($4.18) and traded as low as GBX 242 ($3.14). MaxCyte shares last traded at GBX 243.10 ($3.15), with a volume of 9,254 shares traded.
MaxCyte Stock Down 1.2 %
The business has a 50-day moving average price of GBX 322.33 and a 200-day moving average price of GBX 307.30. The company has a market capitalization of £320.90 million, a price-to-earnings ratio of -8.91 and a beta of 1.13. The company has a quick ratio of 14.38, a current ratio of 9.81 and a debt-to-equity ratio of 8.59.
MaxCyte Company Profile
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients.
Further Reading
- Five stocks we like better than MaxCyte
- How to Invest in Blue Chip Stocks
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- What does consumer price index measure?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Pros And Cons Of Monthly Dividend Stocks
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
